Сравнительный анализ транскриптов клеток кумулюса при использовании различных триггеров овуляции в программах вспомогательных репродуктивных технологий

1. Homburg R. The physiology of ovulation. In: Homburg R. Ovulation induction and controlled ovarian stimulation. A practical guide. Springer;2014: 7-23.

2. Humaidan P., Papanikolaou E.G., Tarlatzis B.C. Reply: GnRHa to trigger final oocyte maturation: a time to reconsider. Hum. Reprod. 2010; 25(3): 807-8.

3. Acevedo B., Gomez-Palomares J.L., Ricciarelli E., Hernández E.R. Triggering ovulation with gonadotropin-releasing hormone agonists does not compromise embryo implantation rates. Fertil. Steril. 2006; 86(6): 1682-7.

4. Casper R.F. Reducing the risk of OHSS by GnRH agonist triggering. J. Clin. Endocrinol. Metab. 2015; 100(12): 4396-8.

5. Ding L.J., Wang B., Shen X.Y., Yan G.J., Zhang N.Y., Hu Y.L. et al. Withdrawal of GnRH agonist decreases oestradiol and VEGF concentrations in high responders. Reprod. Biomed. Online. 2013; 27(2): 131-9.

6. Andersen C., Humaidan P., Ejdrup H., Bungum L., Grondahl M., Westergaard L. Hormonal characteristics of follicular flluid from women receiving either GnRH agonist or hCG for ovulation. Hum. Reprod. 2006; 21(8): 2126-30.

7. Humaidan P., Westergaard L., Mikkelsen L., Fukuda A., Yding Andersen C. Levels of the epidermal growth factor-like peptide amphiregulin in follicular fluid reflect the mode of triggering ovulation: a comparison between gonadotrophin-releasing hormone agonist and urinary human chorionic gonadotrophin. Fertil. Steril. 2011; 95(6): 2034-8.

8. Cerrillo M., Pacheco A., Rodriguez S., Delgado F., Pellicer A., García-Velasco J. Effect of GnRH agonist and hCG treatment on VEGF, angiopoietin-2, and VE-cadherin: trying to explain the link to ovarian hyperstimulation syndrome. Fertil. Steril. 2011; 95(8): 2517-9.

9. Haas J., Ophir L., Barzilay E., Yerushalmi G.M., Yung Y., Kedem A. et al. GnRH agonist vs. hCG for triggering of ovulation – differential effects on gene expression in human granulosa cells. PLoS One. 2014; 9(3): e90359.

10. Gebhardt K.M., Feil D.K., Dunning K.R., Lane M., Russell D.L. Human cumulus cell gene expression as a biomarker of pregnancy outcome after single embryo transfer. Fertil. Steril. 2011; 96(1): 47-52. e2.

11. Ekart J., Mcnatty K., Hutton J., Pitman J. Ranking and selection of MII oocytes in human ICSI cycles using gene expression levels from associated cumulus cells. Hum. Reprod. 2013; 28(11): 2930-42.

12. Мартазанова Б.А., Мишиева Н.Г., Абубакиров А.Н. Замена триггера овуляции как метод профилактики развития синдрома гиперстимуляции яичников. Акушерство и гинекология. 2014; 5: 15-8.

13. Мартазанова Б.А., Мишиева Н.Г., Ведихина И.А., Аксененко А.А., Ипен С.М., Ибрагимова М.Х., Иванец Т.Ю., Абубакиров А.Н. Гормональный профиль после замены триггера овуляции у женщин с высоким риском развития синдрома гиперстимуляции яичников. Акушерство и гинекология. 2015; 6: 84-90.

14. Engmann L., DiLuigi A., Schmidt D., Nulsen J., Maier D., Benadiva C. The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study. Fertil. Steril. 2008; 89(1): 84-91.

15. Gurbuz A.S., Gode F., Uzman M.S., Ince B., Kaya M., Ozcimen N. et al. GnRH agonist triggering affects the kinetics of embryo development: a comparative study. J. Ovarian Res. 2016; 9: 22.

16. Anderson R.A., Sciorio R., Kinnell H., Bayne R.A., Thong K.J., de Sousa P.A., Pickering S. Cumulus gene expression as a predictor of human oocyte fertilisation, embryo development and competence to establish a pregnancy. Reproduction. 2009; 138(4): 629-37.

17. Fragouli E., Wells D., Iager A.E., Kayisli U.A., Patrizio P. Alteration of gene expression in human cumulus cells as a potential indicator of oocyte aneuploidy. Hum. Reprod. 2012; 27(8): 2559-68.

18. Assou S., Haouzi D., De Vos J., Hamamah S. Human cumulus cells as biomarkers for embryo and pregnancy outcomes. Mol. Hum. Reprod. 2010; 16(8): 531-8.

19. Wathlet S., Adriaenssens T., Segers I., Verheyen G., Van de Velde H., Coucke W. et al. Cumulus cell gene expression predicts better cleavage-stage embryo or blastocyst development and pregnancy for ICSI patients. Hum. Reprod. 2011; 26(5): 1035-51.

20. Fujiwara H., Tatsumi K., Kosaka K., Sato Y., Higuchi T., Yoshioka S. et al. Human blastocysts and endometrial epithelial cells express activated leukocyte cell adhesion molecule (ALCAM/CD166). J. Clin. Endocrinol. Metab. 2003; 88(7): 3437-43.

21. Borgbo T., Povlsen B.B., Andersen C.Y., Borup R., Humaidan P., Grøndahl M.L. Comparison of gene expression profiles in granulosa and cumulus cells after ovulation induction with either human chorionic gonadotropin or a gonadotropin-releasing hormone agonist trigger. Fertil. Steril. 2013; 100(4): 994-1001.

22. Yerushalmi G.M., Salmon-Divon M., Yung Y., Maman E., Kedem A., Ophir L. et al. Characterization of the human cumulus cell transcriptome during final follicular maturation and ovulation. Mol. Hum. Reprod. 2014; 20(8): 719-35.

23. de los Santos M.J., García-Láez V., Beltrán-Torregrosa D., Horcajadas J.A., Martínez-Conejero J.A., Esteban F.J. et al. Hormonal and molecular characterization of follicular fluid, cumulus cells and oocytes from pre-ovulatory follicles in stimulated and unstimulated cycles. Hum. Reprod. 2012; 27(6): 1596-605.

Поступила 16.12.2017

Принята в печать 23.12.2017